Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1047 of 6351
-
New immunotherapy combo tested in kids with Hard-to-Treat cancers
Disease control OngoingThe purpose of the study is to determine the recommended dose of durvalumab and tremelimumab (immunotherapy drugs) in pediatric patients with advanced solid and hematological cancers and expand in a second phase to test the efficacy of these drugs once this dose is determined.
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Buckwheat drink may tame blood sugar spikes after meals
Disease control CompletedBuckwheat is a unique crop because is naturally rich in compounds that have shown beneficial effects on glucose metabolism. A constant high glucose level in blood after meal consumption is an independent risk factor for cardiovascular complications and death. In order to prevent…
Sponsor: University of Aberdeen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail aims to tame stomach cancer
Disease control CompletedThis is a randomized, open-label, multi-center, phase III trial to evaluate the efficacy and safety of SHR-1210 plus capecitabine and oxaliplatin sequenced by SHR-1210 plus apatinib versus capecitabine and oxaliplatin as first-line therapy in patients with locally advanced or met…
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:47 UTC
-
New drug shows promise for Tough-to-Treat throat cancer
Disease control CompletedThe study is to evaluate the efficacy of KL-A167 injection in subjects with recurrent/metastatic Nasopharyngeal Carcinoma, as measured by Overall Response Rate (ORR) per the Response Evaluation Criteria in Solid Tumors RECIST Version 1.1
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to stop early lung cancer from returning
Disease control OngoingThis is a Phase III, randomized, placebo-controlled, double-blind, multi-center study assessing the efficacy and safety of durvalumab with SoC SBRT versus placebo with SoC SBRT in patients with unresected clinical Stage I/II lymph node-negative (T1 to T3N0M0) NSCLC. An additiona…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a pill keep endometrial cancer at bay? new study tests rucaparib
Disease control CompletedThis study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer, after 1-2 prior lines of therapy.
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Triple-Drug cocktail aims to keep lung cancer at bay
Disease control OngoingThis phase Ib/II trial studies the best dose of temozolomide and how well it works with niraparib and atezolizumab in treating patients with solid tumors that have spread to other places in the body (advanced) and extensive-stage small cell lung cancer with a complete or partial …
Phase 1/2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Light-Based imaging may spare thousands from unnecessary breast biopsies
Diagnosis CompletedUltrasound-guided diffuse optical tomography (DOT) has demonstrated its potential role in differentiating malignant and benign breast abnormalities and in predicting and monitoring the neoadjuvant chemotherapy (NAC) response of breast cancer. This unique approach employs a commer…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New immunotherapy combo shows promise for tough childhood cancer
Disease control CompletedThis phase II pilot trial studies the side effects and how well dinutuximab and sargramostim work when combined with chemotherapy in patients with high-risk neuroblastoma. Immunotherapy with monoclonal antibodies, such as dinutuximab, may induce changes in the body's immune syste…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Custom-Made vaccine takes on kidney cancer in early trial
Vaccine OngoingThis research study is evaluating a new type of Kidney Cancer vaccine called "Personalized NeoAntigen Cancer Vaccine"as a possible treatment for Kidney Cancer. The following intervention will be involved in this study: * Personalized Neoantigen Vaccine * Poly-ICLC (Hiltonol) * …
Phase 1 • Sponsor: Patrick Ott, MD, PhD • Aim: Vaccine
Last updated Jun 27, 2026 09:01 UTC
-
Machine 'resuscitates' risky donor livers, expands transplant pool
Disease control CompletedThe goal of this observational study is to learn whether extended criteria donor livers can be safely transplanted after sequential hypo- and normothermic machine perfusion in recipients requiring a liver transplant for end-stage liver disease, including a long-term follow-up. Th…
Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Supercharged immune cells take on Hard-to-Treat head and neck cancer
Disease control CompletedEpstein-Barr virus (EBV) infections is known to be a high-risk factor to induce nasopharyngeal cancers. To date, EBV-related head and neck squamous cell carcinoma (HNSCC) is still a major concern in east Asia, especially in China. Concurrent therapies for HNSCC have limited respo…
Phase 1/2 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo may make inoperable lung cancer removable
Disease control Recruiting nowThe purpose of this study is to studying neoadjuvant IBI308, bevacizumab, plus pemetrexed and carboplatin followed by surgery to see how well it works in treating patients with unresectable stage III non-small cell lung cancer.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cell addback could shield kids from deadly infections after transplant
Disease control Recruiting nowThe major morbidities of allogeneic hematopoietic stem cell transplant with non-human leukocyte antigen (HLA) matched siblings are graft vs host disease (GVHD) and life threatening infections. T depletion of the donor hematopoietic stem cell graft is effective in preventing GVHD,…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple surgery replace chemo for this rare Pregnancy-Related cancer?
Disease control Recruiting nowStudy of hysteroscopic repeat curettage as the first-line treatment in low-risk postmolar gestational trophoblastic neoplasia compared with the MTX single drug chemotherapy
Phase 3 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Heart surgery in childhood: a hidden impact on speech and memory?
Knowledge-focused CompletedThe study is aimed to found out expressive speech disorders as a sign of neurocognitive development delay in children with congenital heart defects before and after surgery
Sponsor: Kemerovo State Medical University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can pressurized oxygen boost cord blood transplants?
Disease control OngoingThe UCB transplant is a type of stem cell transplant used to treat cancer of the blood or lymph glands. The UCB transplant has advantages over other types of transplants such as ease of obtaining the umbilical cord blood, absence of donor risks, reduced risks of contagious infect…
Phase 2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Exercise and a diabetes drug: a One-Two punch for blood vessels?
Disease control Recruiting nowThe primary objective of this study is to examine whether exercise training alone, liraglutide treatment alone or exercise training plus liraglutide treatment increases cardiac and muscle capillary blood volume, improves vascular function in the larger conduit vessels, and enhanc…
Phase 4 • Sponsor: University of Virginia • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can imaging cut chemo for breast cancer? new trial seeks answers
Disease control OngoingThis is a multicenter, single arm, phase II study evaluating the efficacy of image-guided de-escalating neoadjuvant treatment with paclitaxel, Herceptin® (trastuzumab), carboplatin, and pertuzumab (PTC-Ptz) in stage II-Ill HER2-positive breast cancer.
Phase 2 • Sponsor: Borstkanker Onderzoek Groep • Aim: Disease control
Last updated Jun 26, 2026 18:53 UTC
-
New drug cocktail shows promise for Hard-to-Treat leukemia
Disease control OngoingThis phase I/II trial studies the best dose of venetoclax when given together with azacitidine and pevonedistat and to see how well it works in treating patients with newly diagnosed acute myeloid leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways t…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC